LENZ Therapeutics, Inc. (LENZ)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 18
+0.3
+6.1475%
$
175.27M Market Cap
- P/E Ratio
4.12% Div Yield
1.12M Volume
- Eps
$ 4.88
Previous Close 
Want to track LENZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
LENZ Therapeutics, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Yigal Nochomovitz Citigroup | 893.58 | $5,551.53 | $4,360.65 | -$1,190.88 | -21.45% |
